CAGRILINTIDE 5MG (R&D)

Cagrilintide – Long-Acting Amylin Analog for Metabolic Research

Cagrilintide is a novel, long-acting amylin analog currently under investigation for its potential in metabolic research. Designed to mimic the physiological effects of the naturally occurring amylin peptide, this compound plays a crucial role in appetite regulation, gastric emptying, and promoting satiety. With its extended half-life and enhanced stability, cagrilintide is an invaluable tool for studies focused on weight management, metabolic disorders, and energy balance.

Key Features:

• Extended Half-Life: Prolonged duration of action reduces the need for frequent administration, making it ideal for research settings.
• Enhanced Stability: Increased stability ensures consistent handling and reliable experimental outcomes.
• Appetite Regulation: Potential for appetite suppression, making it highly relevant for obesity and metabolic disorder studies.
• Combination Therapy Research: Can be studied alongside other metabolic compounds like GLP-1 analogs for synergistic effects.
• Predictable Pharmacokinetics: Optimized pharmacokinetics for reproducible results in research studies.

Mechanism of Action:
Cagrilintide functions as an amylin receptor agonist, binding to specific receptors in the brain that regulate appetite. This binding modulates satiety signaling, reduces food intake, and slows gastric emptying, contributing to a prolonged feeling of fullness. These effects make it a powerful tool in metabolic research, particularly in combination with other compounds.

Research Applications:
Cagrilintide is primarily used in controlled laboratory settings. Supplied in lyophilized powder form, it is reconstituted with bacteriostatic water before use. The reconstituted solution can be administered based on specific research protocols. Its usage should only be performed by qualified professionals under sterile conditions.

Storage Instructions:

• Lyophilized Form: Store in a cool, dry place at temperatures between 2°C and 8°C (36°F to 46°F), away from direct light and moisture.
• Reconstituted Solution: Keep refrigerated and use within 7 to 30 days. Do not freeze to maintain peptide integrity.
• Handling: Avoid freeze-thaw cycles to prevent degradation.

Conclusion:
Cagrilintide is a promising tool for advancing metabolic research, offering extended activity, stability, and appetite-regulating effects. It is designed strictly for research purposes and is not approved for human consumption, diagnosis, or therapy. When handled and stored properly, cagrilintide serves as an effective and reliable agent in the exploration of metabolic health